These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27121091)

  • 41. Oncogenic cAMP responsive element binding protein 1 is overexpressed upon loss of tumor suppressive miR-10b-5p and miR-363-3p in renal cancer.
    Li Y; Chen D; Li Y; Jin L; Liu J; Su Z; Qi Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Mao X; Chen Y; Lai Y
    Oncol Rep; 2016 Apr; 35(4):1967-78. PubMed ID: 26796749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
    Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
    Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
    [TBL] [Abstract][Full Text] [Related]  

  • 43. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
    Pan X; Li Z; Zhao L; Quan J; Zhou L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
    Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of miR-486-5p in regulating renal cell carcinoma cell proliferation and apoptosis via TGF-β-activated kinase 1.
    He Y; Liu J; Wang Y; Zhu X; Fan Z; Li C; Yin H; Liu Y
    J Cell Biochem; 2019 Mar; 120(3):2954-2963. PubMed ID: 30537206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of long-non coding RNA UCA1 as an oncogene in renal cell carcinoma.
    Li Y; Wang T; Li Y; Chen D; Yu Z; Jin L; Ni L; Yang S; Mao X; Gui Y; Lai Y
    Mol Med Rep; 2016 Apr; 13(4):3326-34. PubMed ID: 26935146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis.
    Zhai W; Ma J; Zhu R; Xu C; Zhang J; Chen Y; Chen Z; Gong D; Zheng J; Chen C; Li S; Li B; Huang Y; Xue W; Zheng J
    Br J Cancer; 2018 Aug; 119(5):591-604. PubMed ID: 30082686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
    Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-27a promotes cell proliferation and metastasis in renal cell carcinoma.
    Peng H; Wang X; Zhang P; Sun T; Ren X; Xia Z
    Int J Clin Exp Pathol; 2015; 8(2):2259-66. PubMed ID: 25973137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The functional significance of miR-1 and miR-133a in renal cell carcinoma.
    Kawakami K; Enokida H; Chiyomaru T; Tatarano S; Yoshino H; Kagara I; Gotanda T; Tachiwada T; Nishiyama K; Nohata N; Seki N; Nakagawa M
    Eur J Cancer; 2012 Apr; 48(6):827-36. PubMed ID: 21745735
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of miR‑195‑3p as an oncogene in RCC.
    Jin L; Li X; Li Y; Zhang Z; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Gui Y; Yang S; Mao X; Lai Y
    Mol Med Rep; 2017 Apr; 15(4):1916-1924. PubMed ID: 28260025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-144 inhibits cell proliferation of renal cell carcinoma by targeting MTOR.
    Xiang C; Cui SP; Ke Y
    J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):186-192. PubMed ID: 27072960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differentially expressed microRNA-218 modulates the viability of renal cell carcinoma by regulating BCL9.
    Wang J; Ying Y; Bo S; Li G; Yuan F
    Mol Med Rep; 2016 Aug; 14(2):1829-34. PubMed ID: 27314976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR‑30a‑5p in the tumorigenesis of renal cell carcinoma: A tumor suppressive microRNA.
    Li Y; Li Y; Chen D; Jin L; Su Z; Liu J; Duan H; Li X; Qi Z; Shi M; Ni L; Yang S; Gui Y; Mao X; Chen Y; Lai Y
    Mol Med Rep; 2016 May; 13(5):4085-94. PubMed ID: 27035333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of miR-7 as an oncogene in renal cell carcinoma.
    Yu Z; Ni L; Chen D; Zhang Q; Su Z; Wang Y; Yu W; Wu X; Ye J; Yang S; Lai Y; Li X
    J Mol Histol; 2013 Dec; 44(6):669-77. PubMed ID: 23793934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.
    Lu GJ; Dong YQ; Zhang QM; Di WY; Jiao LY; Gao QZ; Zhang CG
    Int J Clin Exp Pathol; 2015; 8(5):5224-9. PubMed ID: 26191221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. microRNA‑181a‑5p functions as an oncogene in renal cell carcinoma.
    Lai Y; Zhao L; Hu J; Quan J; Chen P; Xu J; Guan X; Lai Y; Ni L
    Mol Med Rep; 2018 Jun; 17(6):8510-8517. PubMed ID: 29693121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Over-expression of telomere binding factors (TRF1 & TRF2) in renal cell carcinoma and their inhibition by using SiRNA induce apoptosis, reduce cell proliferation and migration invitro.
    Pal D; Sharma U; Singh SK; Kakkar N; Prasad R
    PLoS One; 2015; 10(3):e0115651. PubMed ID: 25730259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.
    Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Ueno K; Yamamura S; Zaman MS; Khatri G; Chen Y; Saini S; Majid S; Deng G; Ishii N; Dahiya R
    Int J Cancer; 2011 Apr; 128(8):1793-803. PubMed ID: 20549706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-22 is downregulated in clear cell renal cell carcinoma, and inhibits cell growth, migration and invasion by targeting PTEN.
    Fan W; Huang J; Xiao H; Liang Z
    Mol Med Rep; 2016 Jun; 13(6):4800-6. PubMed ID: 27082730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.